It’s six years since Europe led the way and created a regulatory framework for approving generic versions of biopharmaceuticals, or biosimilars. Now similar legislation has been enacted in the US
The number of trademark applications received in 2010 by the World International Property Organisation have increased by 12.8 per cent compared to the year before
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.